Active ingredient: Nalmefene (as hydrochloride) 18 mg
Dosage form: Film-coated tablets
Pack size: 14 tablets
Manufacturer: H. Lundbeck A/S (Denmark)
Route: Oral use
Selincro® by Lundbeck contains nalmefene, an opioid system modulator that acts on the brain mechanisms responsible for the rewarding effect of alcohol. Unlike classic abstinence-oriented therapy, it is intended to reduce alcohol consumption rather than require complete abstinence.
The product is a prescription-only medicine used as part of a comprehensive treatment program including psychosocial support.
Take one 18 mg tablet once daily, as needed, preferably on days when there is a risk of alcohol consumption, with or without food. The tablet may be taken sublingually to accelerate onset.
Treatment is initiated and reviewed by a physician; regular assessment of treatment response is required.
Store at a temperature not exceeding 30 °C, in the original package. Keep out of reach of children.
It helps reduce alcohol consumption in adults with alcohol dependence who do not require immediate abstinence, as part of a treatment program.
Both act on the opioid system. Selincro (nalmefene) is taken as-needed on drinking-risk days rather than every day.
One 18 mg tablet once daily, as needed, preferably on days when there is a risk of drinking. It may be taken under the tongue for faster onset.
No, the goal is reduced consumption, but abstinence remains an option discussed with your doctor.
Yes. It is a prescription-only medicine used with continuous medical supervision.
Ask a question or inquire about delivery to your country